Loading...
Loading...
Among the 4 tracked institutional investors we monitor, ESLA (ESTRELLA IMMUNOPHARMA INC) is held with a combined value of $854.77K across 594,702 shares. The largest holder is VANGUARD GROUP INC with a position worth $700.07K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$854.77K
Total Shares Held
594,702
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $700.07K | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $66.56K | 0.00% | -48.7% |
| 3 | STATE STREET CORP | $45.85K | 0.00% | - |
| 4 | BlackRock, Inc. | $42.28K | 0.00% | +50.7% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of ESLA with a position worth $700.07K, representing 0.00% of their portfolio. In total, 4 institutional investors hold ESLA with a combined value of $854.77K.
In the most recent quarter, 1 fund opened a new position in ESLA. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $854.77K worth of ESLA stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $700.07K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ESLA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ESLA positions.